Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate safety and efficiency of the triple combination of
capecitabine, lapatinib and vinorelbine in patients with metastatic breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Sponsor GmbH
Collaborators:
Arbeitsgemeinschaft fur Internistische Onkologie Arbeitskreis Klinische Studien GlaxoSmithKline iOMEDICO AG